Not later than 1 year after the date of enactment of this Act, all practitioners who, as of such date of enactment, are permitted to dispense narcotic drugs to individuals (for maintenance treatment or detoxification treatment) pursuant to paragraph (1) or (2) of section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) shall submit a certification to the Secretary of Health and Human Services of compliance with the provisions of such section 303(g), as amended by this Act. Not later than 1 year after the date of enactment of this Act, and every 5 years thereafter, the Comptroller General of the United States shall (A) perform a thorough review of the provision of opioid addiction treatment services in the United States; and (B) submit a report to the Congress on the findings and conclusions of such review. Each report under paragraph (1) shall include (A) an assessment of compliance with the requirements of section 303(g) of the Controlled Substances Act, as amended by this Act; (B) a description of the measures taken by the Secretary of Health and Human Services to ensure such compliance; and (C) an assessment of (i) whether the full range of science and evidencebased treatment options for opioid addiction are fully integrated into treatment; and (ii) the circumstances surrounding medication diversion and misuse. SECTION 1. SHORT TITLE. This Act may be cited as the Opioid Addiction Treatment Modernization Act. SEC.